Abstract:Objective: Patients with severe hypertension can present with systemic signs of thrombotic microangiopathy (TMA), i.e., thrombocytopenia and microangiopathic hemolytic anemia (MAHA), and/or renal failure. Determining the underlying disease causing TMA is essential for selection of the optimal therapy. We aim to elucidate key factors for distinguishing TMA due to malignant hypertension from TMA due to thrombotic thrombocytopenic purpura (TTP). Design and method: We present here a case study focussing on a challenging clinical scenario involving TMA. Through detailed examination of the patient's presentation, laboratory findings, and response to treatment, the report takes you through a diagnostic journey emphasising the unique aspects of TMA in malignant hypertension as compared to TMA in TTP. Results: A 44 year old male was admitted with 2 weeks history of exertional breathlessness, orthopnea and severe headache with vomiting. On examination his BP was severely elevated at 253/150 mmHg and he had features of acute pulmonary edema (APO). Initial investigations Significant anemia (hemolytic picture with elevated LDH, low haptoglobin and Indirect hyperbilirubinemia) with thrombocytopenia. Peripheral blood film revealed fragmented RBCs(2-4/hpf), Severe renal failure Creatinine 757umol/L urea 30.9mmol/L Na 129mmol/L, K 2.6mmol/L. MRI Brain revealed features suggestive of Posterior reversible encephalopathy syndrome (PRES). He was diagnosed with hypertensive emergency complicated by APO, PRES and Acute kitney injury from MAHA. He was admitted to ICU and treated with IV GTN infusion, hydralazine and diuretics. He was also started on hemodialysis. Renal failure work-up-HbA1c 4.4, nonreactive viral markers, negative autoimmune serology (C3/C4 normal, Anti-dsDNA <25, ANA <80, ANCA negative). Secondary Hypertension work-up - negative for Renal artery stenosis, Conns, Cushings, Phaeochromocytoma and Thyroid disorders. ADAMTS-13 Activity: 28%, DCT Negative. He was closely monitored, continued on hemodialysis and his blood pressure well-controlled with consequent improvement in LDH, bilirubin, Hemoglobin, and thrombocytopenia. He did not require to be treated with plasma exchange. Conclusions: The report contributes valuable insights into the differentiation of these two related yet clinically distinct entities, providing guidance for clinicians to appropriately tailor the therapeutic interventions. Further research is essential for refining diagnostic criteria to enhancie the precision of therapeutic strategies in these complex medical scenarios.

TU-FG-204-00: Compliance with the AAPM CT Clinical Practice and Joint Commission Guidelines.

Thrombotic Microangiopathy With Granulomatosis Interstitial Nephritis in an Allogenic Bone Marrow Transplant Patient: A Case Report and Review of the Literature

Evaluation the Risk Factor of Transplantation-Associated Thrombotic Microangiopathy.

Surufatinib-induced renal thrombotic microangiopathy: first case report and review of literature

Fahraeus effect and cell screening during tub flow of human blood. I. Effect of variation of flow rate.

Compact Eight-Way Ka-Band Power Divider/Combiner Based on Double-Layer Finline

Clinical profile and outcomes of De novo posttransplant thrombotic microangiopathy

Thrombotic Microangiopathy After Long-Lasting Treatment by Gemcitabine: Description, Evolution and Treatment of a Rare Case

Clinico-pathological Characteristics and Outcome of Patients with Thrombotic Microangiopathy

Sunitinib-induced endocapillary proliferative glomerulonephritis with IgA2 deposit in addition to thrombotic microangiopathy: a case report

Chronic myeloid leukemia in renal transplantation patients in the era of tyrosine kinase inhibitors: A case report and review of the literature

Outcomes of Early Thrombotic Microangiopathy in Renal Transplantation

Clinical and Renal Biopsy Findings Predicting Outcome in Renal Thrombotic Microangiopathy: A Large Cohort Study from a Single Institute in China

Thrombotic Microangiopathies and the Kidney

DECIPHERING THROMBOTIC MICROANGIOPATHY: A CASE-BASED EXPLORATION OF DISTINGUISHING FEATURES BETWEEN MALIGNANT HYPERTENSION AND THROMBOTIC THROMBOCYTOPENIC PURPURA

Capecitabine-Related Thrombotic Microangiopathy

Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.

Effect of IP3 and ryanodine treatments on the development of bovine parthenogenetic and reconstructed embryos.

Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature

Clinicopathological Features and Outcomes of SLE Patients with Renal Injury Characterised by Thrombotic Microangiopathy.

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer